Eclipsebio Revenue
Biotechnology Research • 
San Diego, California, United States • 21-50 Employees
Eclipsebio revenue & valuation
| Annual revenue | $1,500,000 |
| Revenue per employee | $36,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,800,000 |
| Total funding | $14,000,000 |
Key Contacts at Eclipsebio
Ryan Donnell
Director Of Commercial
Peter Chu
Co-Founder, Ceo And Chairman
Heather Harvey
Director Of Operations
Company overview
| Headquarters | 5770 Oberlin Dr, San Diego, California 92121, US |
| Phone number | +18557272547 |
| Website | |
| NAICS | 541714 |
| Keywords | RNA, Genomics, Next Generation Sequencing, NGS, Rna Sequencing, Rna-Seq, Rna Therapeutics, Eclip, Epitranscriptomics, Rna Sequencing Services, Rna Binding Protein (Rbp), Rna Modifications (M6A), Rna Structure, Ribo-Seq, Ribosome Profiling, Shape-Map, Targetscan, Translatomics, Iclip, Merip, Microrna (Mirna) |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Eclipsebio Email Formats
Eclipsebio uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@eclipsebio.com), used 60.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@eclipsebio.com | 60.9% |
{first name}.{last name} | john.doe@eclipsebio.com | 30.4% |
{first initial} | j@eclipsebio.com | 8.7% |
About Eclipsebio
Eclipsebio develops first-in-class technologies, analyses, and platforms for the development of tomorrow’s RNA-based and RNA-targeting therapies. With our extensive experience in supporting early-stage basic research to evaluating preclinical vaccines and gene therapies, we provide unparalleled support for obtaining deep insights into RNA and therapeutic biology. We offer our solutions as end-to-end partnerships, including custom assay development, for biopharma and biotech companies and as a la carte services. Our areas of support include: - The optimization and characterization of RNA-based vaccines and therapeutics through our eMERGE platform - Multiomic characterization of small molecule and small oligonucleotide targets - Robust validation of on-target, and the identification of off-target, effects from small molecule and small oligonucleotide drugs - Deep profiling of RNA for groundbreaking discoveries in academic research Contact us today to discover how we can provide you with the insights needed for RNA success.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Eclipsebio has 15 employees across 7 departments.
Departments
Number of employees
Eclipsebio Tech Stack
Discover the technologies and tools that power Eclipsebio's digital infrastructure, from frameworks to analytics platforms.
Security
Form builders
JavaScript libraries
JavaScript libraries
Analytics
JavaScript libraries
Font scripts
Databases
JavaScript libraries
Analytics
Advertising
India
Denmark
United Arab Emirates
South AfricaFrequently asked questions
4.8
40,000 users
